| 1. |
Konuma T, Itonaga H, Shimomura Y, Fujioka M, Aoki K, Uchida N, Onizuka M, Jinguji A, Tanaka M, Ueda Y, Katayama Y, Sawa M, Tanaka H, Nakamae H, Kawakita T, Maruyama Y, Takahashi S, Ishimaru F, Kanda J, Ichinohe T, Atsuta Y. Single-unit unrelated cord blood transplantation versus HLA-matched sibling transplantation in adults with advanced myelodysplastic syndrome: A registry-based study from the adult MDS working group of the Japanese society for transplantation and cellular therapy. Hematol Oncol. 2024 Jan;42(1):e3217. doi: 10.1002/hon.3217. EPub 2023 Aug 18. |
| 2. |
Watanabe M, Kanda J, Volt F, Ruggeri A, Suzuki R, Rafii-Elayoubi H, Kimura F, Cappelli B, Kondo E, Scigliuolo GM, Takahashi S, Kenzey C, Rivera Franco MM, Okamoto S, Rocha V, Chevallier P, Sanz J, Furst S, Cornelissen JJ, Milpied NJ, Uchida N, Sugio Y, Kimura T, Ichinohe T, Fukuda T, Mohty M, Peffault de Latour R, Atsuta Y, Gluckman E. Cord blood transplantation for adult lymphoid neoplasms in Europe and Japan. Blood Adv. 2024 Feb 13;8(3):640-652. doi: 10.1182/bloodadvances.2023010598. EPub 2023 Dec 15. |
| 3. |
Fukunaga K, Ikegame K, Nakamae H, Doki N, Fukuda T, Kondo Y, Ara T, Eto T, Mori Y, Matsuoka KI, Kanda Y, Onizuka M, Atsuta Y, Ichinohe T, Morishima S, Kanda J; JSTCT HLA Working Group. HLA haploidentical stem cell transplantation from HLA homozygous donors to HLA heterozygous donors may have lower survival rates than haploidentical transplantation from HLA heterozygous donors to HLA heterozygous donors: a retrospective nationwide analysis. Int J Hematol. 2024 Feb;119(2):173-182. doi: 10.1007/s12185-023-03693-w. EPub 2024 Jan 17. |
| 4. |
Shimomura Y, Kitamura T, Konuma T, Nakaya Y, Doki N, Sawa M, Nakamae H, Eto T, Nishida T, Ohigashi H, Ota S, Onizuka M, Hiramoto N, Kawakita T, Kanda J, Ichinohe T, Atsuta Y, Itonaga H. Hematopoietic stem cell transplantation from haploidentical offspring donors using post-transplant cyclophosphamide versus human leukocyte antigen-matched siblings in older patients with myelodysplastic syndrome. Am J Hematol. 2024 Feb;99(2):E42-E45. doi: 10.1002/ajh.27160. EPub 2023 Nov 15. |
| 5. |
Kurita N, Imahashi N, Chiba S, Tanaka M, Kobayashi H, Uchida N, Kuriyama T, Anzai N, Nawa Y, Nakano N, Ara T, Onizuka M, Katsuoka Y, Koi S, Kimura T, Ichinohe T, Atsuta Y, Kanda J; Donor/Source Working Group of the Japanese Society for Transplantation and Cellular Therapy. Comparison of fludarabine-based conditioning regimens in adult cord blood transplantation for myeloid malignancy: A retrospective, registry-based study. Am J Hematol. 2024 Feb;99(2):236-244. doi: 10.1002/ajh.27172. Epub 2024 Jan 2. |
| 6. |
Ureshino H, Ueda Y, Fujisawa S, Usuki K, Tanaka H, Okada M, Kowata S, Murai K, Hirose A, Shindo M, Kumagai T, Takeoka T, Kamachi K, Kidoguchi K, Shindo T, Iyama S, Inamura J, Nakao T, Kobayashi T, Kawata E, Ohkawara H, Ikezoe T, Kawaguchi A, Kimura S. KIR3DL1-HLA-Bw status in CML is associated with achievement of TFR: the POKSTIC Trial, a Multicentre Observational Study. Blood Neoplasia. 2024 Feb 9;1(1):100001. doi: 10.1016/j.bneo.2024.100001. eCollection 2024 Mar. |
| 7. |
Kawata T, Shimizu T, Shindo T, Fujiwara K, Morimoto S, Watanabe M. Tucidinostat restores CCR4 expression in adult T-cell leukemia/lymphoma. Haematologica. 2024 Mar 1;109(3):1007-1009. doi: 10.3324/haematol.2023.283266. EPub 2023 Oct 5. |
| 8. |
Watanabe M, Konuma T, Imahashi N, Terakura S, Seo S, Morishima S, Uchida N, Doki N, Tanaka M, Nishida T, Kawakita T, Eto T, Takahashi S, Sawa M, Uehara Y, Kim SW, Ishimaru F, Ichinohe T, Fukuda T, Atsuta Y, Kanda J.Scoring system for optimal cord blood unit selection for single cord blood transplantation. Cytotherapy. 2024 Mar;26(3):286-298.:S1465-3249(23)01128-3. doi: 10.1016/j.jcyt.2023.12.001. EPub 2023 Dec 27 |
| 9. |
Doi-Fujita A, Edahiro T, Ureshino H, Yoshida T, Ichinohe T. Facial nerve palsy and hypopituitarism associated with immunoglobulin G4-related disease in an elderly man. Am J Med Sci. 2024 Mar;367(3):e35-e36. doi: 10.1016/j.amjms.2023.11.020. EPub Nov 26. |
| 10. |
Imahashi N, Kurita N, Konuma T, Takahashi S, Nishida T, Tanaka M, Nakamae H, Kawakita T, Ota S, Doki N, Onishi Y, Sawa M, Ozeki K, Hiramoto N, Onizuka M, Ishimaru F, Ichinohe T, Atsuta Y, Kanda J. Effect of conditioning regimens and GVHD prophylaxis on the outcomes of umbilical cord blood transplantation performed with cyclophosphamide/total-body irradiation-based regimens. Transplant Cell Ther. 2024 Mar;30(3):318.e1-318.e11. doi: 10.1016/j.jtct.2023.12.004. EPub 2023 Dec 9. |
| 11. |
Shimomura Y, Kitamura T, Murata M, Matsuo K, Ito Y, Ichinohe T, Hashii Y, Goto H, Kato K, Ishimaru F, Sato A, Onizuka M, Yanagisawa A, Ohbiki M, Tabuchi K, Atsuta Y, Fukuda T, Kanda J, Terakura S. Impact of center volume on chronic graft versus host disease in patients with allogeneic stem cell transplantation. Transplant Cell Ther. 2024 Mar;30(3):326.e1-326.e14. doi: 10.1016/j.jtct.2024.01.056. EPub 2024 Jan 11. |
| 12. |
Yanagisawa R, Shindo M, Shinohara A, Kuwatsuka Y, Nakase K, Kimura F, Shingai N, Nishida T, Fukuda T, Sakurai M, Kurokawa M, Koike T, Ota S, Takada S, Onizuka M, Uchida N, Tanaka M, Noguchi M, Maruyama Y, Hagihara M, Ichinohe T, Atsuta Y, Kanda J, Nakasone H, Toubai T. Comparative Analysis of Allogeneic Bone Marrow Transplantation Outcomes Between Japanese and Non-Japanese Populations. Transplant Proc. 2024 Mar;56(2):416-421. doi: 10.1016/j.transproceed.2024.01.049. EPub 2024 Feb 8. |
| 13. |
Watanabe T, Yamamoto Y, Kurahashi Y, Kawazoe K, Kidoguchi K, Ureshino H, Kamachi K, Yoshida-Sakai N, Fukuda-Kurahashi Y, Nakamura H, Okada S, Sueoka E, Kimura S. Reprogramming of pyrimidine nucleotide metabolism supports vigorous cell proliferation of normal and malignant T cells. Blood Adv. 2024 Mar 26;8(6)1345-1358. doi: 10.1182/bloodadvances.2023011131. |
| 14. |
Mizuno S, Takami A, Kawamura K, Harada K, Masayoshi M, Yano S, Ito A, Ozawa Y, Ouchi F, Ashida T, Nawa Y, Ichinohe T, Fukuda T, Atsuta Y, Yanada M. Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with BCR::ABL1 fusion. EJHaem. 2024 Mar 30;5(2):369-378. doi: 10.1002/jha2.877. |
| 15. |
Yorichika Y, Neshige S, Edahiro T, Aoki S, Maruyama H. An early neurological indicator of immune effector cell-associated neurotoxicity syndrome. Cureus. 2024 Mar 30;16(3):e57298. doi: 10.7759/cureus.57298. |
| 16. |
Masui H, Shindo M, Inoue Y, Sugiyama M, Ueda A, Shindo T, Okoshi K, Kinoshita K. Successful treatment of severe splenic lymphoma‑associated hemophagocytic syndrome by splenectomy and subsequent chemotherapy: A case report. Oncol Lett. 2024 Mar 22;27(5):222. doi: 10.3892/ol.2024.14355. eCollection 2024 May. |
| 17. |
Ureshino H, Kamachi K, Kimura S. Second Treatment-Free Remission Attempt in Patients with Chronic Myeloid Leukemia. Clin Lymph Myeloma Leuk. 2024 Apr; 24(4): e138-e141. doi.org/10.1016/j.clml.2023.12.011. Epub 2023 Dec 29. |
| 18. |
Kim H, Mizuno K, Masuda K, Sakurai M, Ara T, Naito K, Uehara Y, Yamamoto G, Osada M, Machida S, Horio T, Fukushima K, Mori Y, Ichinohe T, Fukuda T, Atsuta Y, Kataoka K. A nationwide retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult hemophagocytic lymphohistiocytosis. Transplant Cell Ther. 2024 Apr;30(4):419.e1-419.e12. doi: 10.1016/j.jtct.2024.01.071. EPub 2024 Jan 22. |
| 19. |
Yanada M, Yano S, Kuwatsuka Y, Kawamura K, Fukuda T, Ichinohe T, Hashii Y, Goto H, Kato K, Ishimaru F, Sato A, Onizuka M, Matsuo K, Ito Y, Yanagisawa A, Ohbiki M, Tabuchi K, Atsuta Y, Kanda J, Konuma T. The effect of center experience on allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia. Bone Marrow Transplant. 2024 Apr;59(4):541-549. doi: 10.1038/s41409-024-02222-5. EPub 2024 Feb 6. |
| 20. |
Nishiwaki S, Sugiura I, Fujisawa S, Hatta Y, Atsuta Y, Doki N, Kurahashi S, Ueda Y, Dobashi N, Maeda T, Matsumura I, Tanaka M, Kako S, Ichinohe T, Fukuda T, Ohtake S, Ishikawa Y, Miyazaki Y, Kiyoi H; Japan Adult Leukemia Study Group. Utility of allogeneic stem cell transplantation for adult Ph+ALL with complete molecular remission. Am J Hematol. 2024 May;99(5):806-815. doi: 10.1002/ajh.27237. EPub 2024 Feb 5. |
| 21. |
Nakaya Y, Nakamae H, Nishikubo M, Kondo E, Fukuda T, Hiramoto N, Mori Y, Nagafuji K, Eto T, Onishi Y, Uchida N, Ishikawa J, Matsuoka KI, Yui S, Takase K, Kawakita T, Kanda J, Ichinohe T, Atsuta Y, Kako S. Peripheral blood stem cell transplantation using HLA-haploidentical donor with post-transplant cyclophosphamide versus HLA-matched sibling donor for lymphoma. Bone Marrow Transplant. 2024 May;59(5):630-636. doi: 10.1038/s41409-024-02229-y. EPub 2024 Feb 14. |
| 22. |
Sakatoku K, Murata M, Shimazu Y, Uchida N, Yoshihara S, Uehara Y, Takahashi S, Kobayashi H, Tanaka H, Nakano N, Ishimaru F, Ichinohe T, Atsuta Y, Nagamura-Inoue T, Nakamae H. Comparison of haploidentical transplantation and single cord blood transplantation for myelofibrosis. Bone Marrow Transplant. 2024 May;59(5):705-707. doi: 10.1038/s41409-024-02244-z. EPub 2024 Feb 20. |
| 23. |
Jo T, Ueda T, Akahoshi Y, Kondo T, Uchida N, Tanaka M, Nakamae H, Doki N, Ota S, Sawa M, Ohigashi H, Maruyama Y, Takayama N, Nishida T, Hiramoto N, Katayama Y, Kanda Y, Ichinohe T, Atsuta Y, Arai Y; Japanese Society for Transplantation and Cellular Therapy (JSTCT). First complete remission favours haploidentical haematopoietic stem cell transplantation with post-transplant cyclophosphamide over cord blood transplantation in acute lymphoblastic leukaemia. Br J Haematol. 2024 May;204(5):1913-1919. doi: 10.1111/bjh.19372. EPub 2024 Feb 29. |
| 24. |
Miyamoto S, Niizato D, Tomomasa D, Nishimura A, Hoshino A, Kamiya T, Isoda T, Takagi M, Kajiwara M, Azumi S, Hirabayashi S, Sakamoto K, Kishimoto K, Miyamura T, Umeda K, Hirose A, Keino D, Yanagimachi M, Kanda K, Sakai Y, Ikawa Y, Watanabe K, Tanaka K, Mori T, Ichinohe T, Sakaguchi H, Morio T, Kanegane H. Allogeneic hematopoietic cell transplantation using alemtuzumab in Asian patients with inborn errors of immunity. J Clin Immunol. 2024 May 22;44(6):126. doi: 10.1007/s10875-024-01734-5. |
| 25. |
Kurosawa S, Shimomura Y, Ishiyama K, Fuse K, Shimazu Y, Doki N, Uchida N, Tanaka M, Takahashi S, Sakurai M, Kobayashi H, Katayama Y, Takada S, Ozeki K, Nakamae H, Ishimaru F, Kanda Y, Ichinohe T, Atsuta Y, Itonaga H. Updated comparable efficacy of cord blood transplantation for chronic myelomonocytic leukaemia: a nationwide study. Bone Marrow Transplant. 2024 Jun:59(6):742-750. doi: 10.1038/s41409-024-02223-4. EPub 2024 Feb 8. |
| 26. |
Abe-Chayama H, Kawase T, Ichinohe T, Ishida Y, Tateno C, Hijikata M, Chayama K. Detection and analysis of HBV-specific stem cell memory T cells in vitro and in vivo. FEBS Lett. 2024 Jun;598(11):1354-1365. doi: 10.1002/1873-3468.14842. EPub 2024 Apr 9. |
| 27. |
Morishima S, Yoshimitsu M, Shindo T, Utsunomiya A, Ishida T, Ito A, Nakano N, Kawakita T, Eto T, Suehiro Y, Itonaga H, Mori Y, Miyazaki Y, Kanda J, Uchida N, Sawayama Y, Tomori S, Ichinohe T, Atsuta Y, Fukuda T, Kato K; ATL Working Group of the Japanese Society for Transplantation and Cellular Therapy. Individual HLAs affect survival after allogeneic stem cell transplantation in adult T-cell leukaemia/lymphoma. HLA. 2024 Jun;103(6):e15555. doi: 10.1111/tan.15555. |
| 28. |
Ureshino H, Takeda Y, Kamachi K, Ono T, Iriyama N, Ohtsuka E, Sakaida E, Kimura S. A higher neutrophil count is associated with favorable achievement of treatment-Free remission in patients with chronic myeloid leukemia who received second generation tyrosine kinase inhibitor as frontline treatment. Clin Pract. 2024 Jun 21;14(4):1216-1224. doi: 10.3390/clinpract14040097. |
| 29. |
Konishi T, Matsuda K, Itonaga H, Doki N, Nishida T, Matsuoka KI, Ikeda T, Kanda Y, Fukuda T, Kanda J, Nakamae H, Imada K, Ueda Y, Ichinohe T, Atsuta Y, Ishiyama K. Impact of Early Cytomegalovirus Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation on Relapse in Patients With Myelodysplastic Syndrome: A Nationwide Retrospective Study From Adult Myelodysplastic Syndrome Working Group of the JSTCT. Transplant Cell Ther. 2024 Jul;30(7):685.e1-685.e12. doi: 10.1016/j.jtct.2024.04.019. EPub 2024 Apr 30. |
| 30. |
Shimazu Y, Kanda J, Suzuki K, Wada A, Kikuchi T, Ikeda T, Tsukada N, Miwa A, Itagaki M, Kako S, Nishiwaki K, Ota S, Fujiwara SI, Kataoka K, Doki N, Sawa M, Hiramoto N, Nishikawa A, Imai T, Ichinohe T, Kanda Y, Atsuta Y, Kawamura K. The impact of daratumumab pretreatment on multiple myeloma patients undergoing autologous transplantation. Cancer Sci. 2024 Jul;115(7):2384-2395. doi: 10.1111/cas.16198. EPub 2024 May 16. |
| 31. |
Kurisu N, Hiyama T, Harada Y, Fukushima N, Katsuya N, Ureshino H, Ichinohe T, Kiuchi Y. Vitreoretinal Lymphoma in a Patient with Rheumatoid Arthritis with a History of Methotrexate-associated Lymphoproliferative Disorders. Ocul Immunol Inflamm. 2024 Aug:32(6):1070-1075. doi: 10.1080/09273948.2022.2144384. Epub 2022 Nov 17. |
| 32. |
Konuma T, Miyao K, Nakasone H, Ouchi F, Fukuda T, Tanaka M, Ozawa Y, Ota S, Kawakita T, Uchida N, Sawa M, Katayama Y, Hiramoto N, Eto T, Ichinohe T, Atsuta Y, Kanda J; Donor/Source Working Group of the Japanese Society for Transplantation and Cellular Therapy. Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical sibling donors for hematological malignancies in 6064 adults from 2003 to 2020: different impacts on survival according to time period. Cytotherapy. 2024 Aug;26(8):910-920. doi: 10.1016/j.jcyt.2024.03.489. Epub 2024 Mar 30. |
| 33. |
Itonaga H, Miyazaki Y, Fujioka M, Aoki J, Doki N, Nishida T, Fukuda T, Uchida N, Ueda Y, Uehara Y, Katayama Y, Ota S, Kawakita T, Kato J, Matsuoka KI, Eto T, Onizuka M, Ichinohe T, Atsuta Y, Ishiyama K. Prognostic impact of the conditioning intensity on outcomes after allogeneic transplantation for MDS with low blasts: a nationwide retrospective study by the adult MDS working group of the Japan Society for Transplantation and Cellular Therapy. Bone Marrow Transplant. 2024 Aug;59(8):1107-1117. doi: 10.1038/s41409-024-02297-0. EPub 2024 May 7. |
| 34. |
Kuwatsuka Y, Ito H, Tabuchi K, Konuma T, Uchida N, Inamoto Y, Inai K, Nishida T, Ikegame K, Eto T, Katayama Y, Kataoka K, Tanaka M, Takahashi S, Fukuda T, Ichinohe T, Kimura F, Kanda J, Atsuta Y, Matsuo K. Trends in allogeneic hematopoietic cell transplantation survival using population-based descriptive epidemiology method: analysis of national transplant registry data. Bone Marrow Transplant. 2024 Sep;59(9):1295-1301. doi: 10.1038/s41409-024-02326-y. Epub 2024 Jun 19. |
| 35. |
Maida S, Nakagawa H, Ureshino H, Kajihara K, Yamazaki S, Ichinohe T. Dysmorphic megakaryocytes in TAFRO syndrome: A case series from a single institute. Blood Cells Mol Dis. 2024 Sep;108:102870. doi: 10.1016/j.bcmd.2024.102870. Epub 2024 Jun 8. |
| 36. |
Kanda J, Mitsuyoshi T, Sakurai M, Nishimori H, Murata M, Uchida N, Doki N, Inamoto Y, Nishida T, Tanaka M, Katayama Y, Eto T, Matsuoka KI, Yoshihara S, Sawa M, Kawakita T, Jun G, Kurata M, Ichinohe T, Fukuda T, Teshima T, Atsuta Y, Terakura S. Real-World Outcomes of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation in Japan: Retrospective Analysis of the Transplant Registry Unified Management Program Registry. Transplant Cell Ther. 2024 Sep;30(9):907.e1-907.e16. doi: 10.1016/j.jtct.2024.06.023. Epub 2024 Jul 2. |
| 37. |
Tanaka M, Horimasu Y, Kawamoto K, Edahiro T, Yamaguchi K, Sakamoto S, Masuda T, Nakashima T, Iwamoto H, Fujitaka K, Hamada H, Ichinohe T, Hattori N. Primary pulmonary extranodal NK/T-cell lymphoma diagnosed by thoracoscopic lung biopsy: A case report. Respir Med Case Rep. 2024 Sep 26;52:102127. doi: 10.1016/j.rmcr.2024.102127. |
| 38. |
Kurosawa S, Fukuda T, Ichinohe T, Hashii Y, Kanda J, Goto H, Kato K, Yoshimitsu M, Ishimaru F, Sato A, Onizuka M, Matsuo K, Ito Y, Yanagisawa A, Ohbiki M, Tabuch K, Atsuta Y, Arai Y; Japanese Society for Transplantation and Cellular Therapy (JSTCT). Center effect on allogeneic hematopoietic stem cell transplantation outcomes for B-cell acute lymphoblastic leukemia. Cytotherapy. 2024 Oct;26(10):1185-1192. doi: 10.1016/ j.jcyt.2024.05.004. Epub 2024 May 9. |
| 39. |
Ureshino H, Takahashi N, Ikezoe T, Kameoka Y, Kimura S, Fukushima N, Ichinohe T, Takamori A, Kawaguchi A, Miura M, Kimura S. A lower initial dose of bosutinib for patients with chronic myeloid leukemia patients resistant and/or intolerant to prior therapy: a single-arm, multicenter, phase 2 trial (BOGI trial). Int J Hematol. 2024 Oct;120(4):492-500. doi: 10.1007/s12185-024-03830-z. Epub 2024 Aug 13. |
| 40. |
Rai S, Kim WS, Ando K, Choi I, Izutsu K, Tsukamoto N, Maruyama D, Tsukasaki K, Kuroda J, Ando J, Hidaka M, Koh Y, Kato H, Uchida T, Yang DH, Ishitsuka K, Ishizawa K, Kim JS, Lee HG, Minami H, Eom HS, Kurosawa M, Lee JH, Lee JS, Lee WS, Nagai H, Shindo T, Yoon DH, Yoshida S, Gillings M, Onogi H, Tobinai K. Long-term efficacy and safety of tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: final analysis of phase IIb results. Haematologica. 2024 Oct 1;109(10):3357-3362. doi: 10.3324/haematol.2023.283992. |
| 41. |
Kawamura S, Tamaki M, Konuma T, Onizuka M, Sakaida E, Hayashi H, Doki N, Nishida T, Sawa M, Ohigashi H, Fukuda T, Ishikawa J, Matsuoka KI, Kawakita T, Tanaka M, Ishimaru F, Ichinohe T, Atsuta Y, Kanda Y, Yakushijin K, Kanda J, Nakasone H. Superiority of BM over PBSC for recipients with pre-transplant lung dysfunction in HLA-matched allogeneic HCT. Cytotherapy. 2024 Nov;26(11):1353-1361. doi: 10.1016/j.jcyt.2024.06.006. Epub 2024 Jun 12. |
| 42. |
Edahiro T, Ureshino H, Nakamori M, Shindo T, Ichinohe T. Acalabrutinib and obinutuzumab for chronic lymphocytic leukemia complicated with peripheral neuropathy. Cureus. 2024 Nov 28:16(11): e74703. doi:10.7759/cureus.74703 |
| 43. |
Miura Y, Fujii-S, Ichinohe T. Cell-based and extracellular vesicle-based MSC therapies for acute radiation syndrome affecting organ systems. J Radiat Res. 2024 Dec 16;65(Supplement_1):i80-i87. doi: 10.1093/jrr/rrae009. |
